| Bioactivity | 1-(b-D-Xylofuranosyl)-N6-(p-methoxybenzyl) adenine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-(b-D-Xylofuranosyl)-N6-(p-methoxybenzyl) adenine |
| Formula | C18H21N5O5 |
| Molar Mass | 387.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
1-(b-D-Xylofuranosyl)-N6-(p-methoxybenzyl) adenine
CAS: F: C18H21N5O5 W: 387.39
1-(b-D-Xylofuranosyl)-N6-(p-methoxybenzyl) adenine is a purine nucleoside analog. Purine nucleoside analogs have broad a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.